Multidrug-Resistant Organisms (MDROs): Superbug Threats and Control

Multidrug-resistant organisms (MDROs) are bacteria or fungi resistant to multiple antimicrobial classes, severely limiting treatment options. They are a global public health crisis.

Key MDRO Categories

• MRSA: Methicillin-resistant Staphylococcus aureus
• VRE: Vancomycin-resistant Enterococci
• CRE: Carbapenem-resistant Enterobacterales (e.g., Klebsiella, E. coli)
• ESBL-producers: Extended-spectrum β-lactamase-producing Gram-negatives
• MDR-Pseudomonas, MDR-Acinetobacter
• Candida auris (multidrug-resistant yeast)

Transmission

• Direct contact (contaminated hands of healthcare workers)
• Contaminated surfaces/equipment (bedrails, stethoscopes)
• Patient-to-patient via shared devices

Clinical Impact

• Higher mortality, longer hospitalization, increased costs
• Limited antibiotics (often toxic: colistin, tigecycline, polymyxins)
• Infection control challenges (isolation, cohorting, enhanced cleaning)

Prevention & Control

• Antimicrobial stewardship: Optimize antibiotic use, de-escalate, limit duration.
• Hand hygiene: WHO 5 Moments, alcohol-based rub.
• Contact precautions: Gowns/gloves for colonized/infected patients.
• Surveillance cultures: Active detection (e.g., rectal swabs for CRE).
• Environmental cleaning: EPA-registered disinfectants, UV/HPV adjuncts.
• Device management: Catheter/central line bundles, early removal.

MDRO control requires coordinated institutional and community efforts.